Industry & Policy News

[Nature] People with HIV are the latest group to benefit from the new generation of anti-obesity drugs. If early data about the treatments’ effects are confirmed, the drugs could become key to controlling the metabolic problems often caused by anti-HIV medications.

[News Medical Life Sciences] The University of Miami announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.

[Can-Fite BioPharma, Ltd.] Can-Fite BioPharma, Ltd. announced it received a Notice of Allowance from the Canadian Intellectual Property Office for its patent application titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.

[University of Saskatchewan College of Medicine] Dr. Angelica Lang's research project received $348,076 over four years from the Canadian Institutes of Health Research Project Grant program. Lang’s research explores relationships between types of surgeries and subsequent movement pattern alterations, as well as their implications for post-surgery rehabilitation.

[News Medical Life Sciences] The University of Miami announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.

[National Cancer Institute] Cancer Grand Challenges has selected five new global research teams that will address the following challenges in cancer: reducing cancer inequities, understanding the mechanisms of early-onset cancers, developing drugs for solid tumors in children, and broadening our knowledge about how T cells recognize cancer cells.